跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 329,494 条关于
“Immunoglobulin A Nephropathy”
全部
329,494
临床试验
278,936
药物
5,813
机构
4,002
资讯
40,743
5个月前
Calliditas Therapeutics Presents New NefIgArd Trial Data Supporting Nefecon's Gut-Targeted Mechanism in IgA Nephropathy
9个月前
FDA Grants Accelerated Approval to Otsuka's Voyxact for IgA Nephropathy, First APRIL-Targeting Therapy
去年
FDA Grants Breakthrough Therapy Designation to OMS721 for IgA Nephropathy
去年
NEFECON® Included in China's National Reimbursement Drug List for IgA Nephropathy
去年
Taiwan TFDA Approves Nefecon for Primary IgA Nephropathy Treatment
去年
Otsuka's Sibeprenlimab Shows Positive Phase 3 Interim Results for IgA Nephropathy
去年
Otsuka's Sibeprenlimab Achieves 51% Reduction in Proteinuria for IgA Nephropathy, Intensifying Competition with Vera Therapeutics
去年
Vera Therapeutics' Atacicept Achieves 46% Proteinuria Reduction in Phase 3 IgA Nephropathy Trial
去年
NEFECON Receives Full NMPA Approval for IgA Nephropathy Treatment in China, Removing Proteinuria Restrictions
2年前
Novartis's Atrasentan Shows Promise with Projected $229M Revenue by 2033 for Kidney Diseases
第 1 页，共 4075 页
上一页
下一页
